Congratulations to our portfolio company Enko Chem on their Series C funding round of $70M, led by Nufarm. We look forward to seeing how their machine learning-based discovery pushes forward the industry’s R&D. Read the full Press Release here Read More
Year: 2022
Vir to extend COVID-19 treatment approach to HIV, malaria with $50M from Gates Foundation
The Bill & Melinda Gates Foundation has committed $40 million in equity investment and $10 million in grant funding to Vir Biotechnology for the development of therapies against HIV and Malaria, Vir announced Friday. Read the full Press Release here.